We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

IGF-MTX Conjugate in the Treatment of Myelodysplastic Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03175978
Recruitment Status : Terminated (Funding)
First Posted : June 5, 2017
Last Update Posted : June 13, 2022
Information provided by (Responsible Party):
IGF Oncology, LLC

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : June 30, 2021
Actual Study Completion Date : September 30, 2021